K-numberK250782
Device nameFractional CO2 Laser Machine
ApplicantZhengzhou PZ Laser Slim Technology Co., Ltd.
Product codeGEX
Device classClass II
Decision dateJun 12, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Fractional CO2 Laser Machine is a surgical laser device that emits CO2 laser light at 10.6 micrometers wavelength for two primary uses: fractional mode for ablative skin resurfacing, and impulse mode for incision, excision, ablation, vaporization, and coagulation of soft tissues across multiple surgical specialties including dermatology, plastic surgery, ENT, gynecology, neurosurgery, and dental surgery.

Technological characteristics

The proposed device uses a 30W CO2 laser at 10.6 μm wavelength with pulse durations of 100-5,000 microseconds, maximum fractional pulse energy of 150 mJ, repetition rate up to 1,000 Hz, and fractional spot patterns delivering up to 289 spots per square centimeter with spot sizes of 100-200 micrometers. It features an LCD touchscreen interface, articulate optical guide arm, and air cooling. The electrical requirement differs from the predicate (100-120V versus 100-240VAC), though the device passed electrical safety and EMC testing.

Test standards cited

IEC 60601-1 (medical electrical equipment general safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-2-22 (surgical laser equipment), IEC 60825-1 (laser product safety classification), ISO 10993-5 (cytotoxicity testing), ISO 10993-10 (skin sensitization), and ISO 10993-23 (irritation testing).

Substantial equivalence argument

The proposed device is substantially equivalent because it shares identical laser type, wavelength, output power, pulse parameters, fractional spot density, scan area, and biocompatibility safety profile with the predicate Ilooda Fraxis CO2 Laser. Although the electrical input specifications differ, safety and EMC testing confirmed the device operates normally under its specified requirements. The inter-beam spacing, calculated from identical microbeam diameter and spot density, should match the predicate device. All critical performance and safety characteristics are identical, demonstrating equivalent safety and effectiveness for the same indications of use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →